Regentis Biomaterials Ltd. (RGNT)
NASDAQ: RGNT · Real-Time Price · USD
7.49
-0.01 (-0.13%)
At close: Dec 5, 2025, 4:00 PM EST
7.30
-0.19 (-2.54%)
After-hours: Dec 5, 2025, 8:00 PM EST
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $36.92 million as of December 5, 2025.
Market Cap
36.92M
Enterprise Value
41.95M
1-Year Change
n/a
Ranking
Category
Stock Price
7.49
Market Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $36.92M, a decrease of -6.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 29.61M | -24.91% |
View and export this data all the way back to 2025.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 909.45B |
| Johnson & Johnson | 490.17B |
| AbbVie | 405.35B |
| UnitedHealth Group | 302.92B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 252.92B |
| Abbott Laboratories | 217.10B |